SCHEMBL711326

SCHEMBL711326

O=CC1CC2CC1C1CCCC21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
CA12 O43570 2/20 0.36
GMNN O75496 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
LMNA P02545 2/20 0.36
BLM P54132 2/20 0.36
CA9 Q16790 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
SGMS1 Q86VZ5 1/20 0.36
SGMS2 Q8NHU3 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
ALOX12 P18054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31468234 1.00 MAPT (0.36) MAPTCA12GMNNALDH1A1CA1
SCHEMBL9912685 0.77
SCHEMBL9912687 0.77
SCHEMBL31465584 0.75
SCHEMBL29766163 0.75
SCHEMBL6419264 0.74 NPC1 (0.34) MAPTCA12GMNNALDH1A1CA1
SCHEMBL6419262 0.74 NPC1 (0.34) MAPTCA12GMNNALDH1A1CA1
SCHEMBL5445621 0.73 MAPT (0.32) MAPTCA12GMNNALDH1A1CA1
SCHEMBL20663556 0.73 MAPT (0.32) MAPTCA12GMNNALDH1A1CA1
SCHEMBL30362275 0.72 NPC1 (0.35) MAPTCA12GMNNALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety THE PROCTER & GAMBLE COMPANY (US) 2025-02-25 US claimed
US-20250051370-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2025-02-13 US claimed
US-20220064191-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2022-03-03 US claimed
EP-3218425-B1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2020-05-13 EP claimed
US-20190274938-A1 PERFUME COMPOSITION CAPABLE OF MASKING ODOR OF FORMULATION CONTAINING AMINE LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2019-09-12 US claimed
EP-3247779-B1 PHOTOLABILE ACETAL AND KETAL COMPOUNDS FOR THE CONTROLLED RELEASE OF ACTIVE VOLATILE CARBONYL COMPOUNDS FIRMENICH & CIE (CH) 2019-03-13 EP claimed
WO-2017196762-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2017-11-16 WO claimed
US-20170327647-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2017-11-16 US claimed
EP-3218425-A1 SILICONE COMPOUNDS The Procter and Gamble Company (US) 2017-09-20 EP claimed
EP-2822682-B1 MICROCAPSULES AND USES THEREOF FIRMENICH & CIE (CH) 2017-04-26 EP claimed
EP-2748208-B1 PHOTOLABILE LATEX FOR THE RELEASE OF PERFUMES FIRMENICH & CIE (CH) 2016-06-22 EP claimed
WO-2016077513-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2016-05-19 WO claimed
US-20160137674-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2016-05-19 US claimed
US-9334464-B2 Microcapsules and uses thereof FIRMENICH SA (CH) 2016-05-10 US claimed
US-9315763-B2 Photolabile latex for the release of perfumes FIRMENICH SA (CH) 2016-04-19 US claimed
EP-2822682-A1 MICROCAPSULES AND USES THEREOF Firmenich SA (CH) 2015-01-14 EP claimed
US-20140323376-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2014-10-30 US claimed
EP-2152673-B1 3- TO 7-MEMBERED 1,3-DIAZA-4-OXO-HETEROCYCLIC DERIVATIVES CAPABLE OF RELEASING ACTIVE ALDEHYDES OR KETONES FIRMENICH & CIE (CH) 2014-08-20 EP claimed
WO-2013079435-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2013-06-06 WO claimed
EP-1316554-B1 Acetal derivatives of 2-methyl-2secbutyl-1,3-propandiol and their use as fragrance CELANESE CHEM EUROPE GMBH (DE) 2006-04-26 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137674-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS MAPT 904/4885CA12 3610/4885GMNN 1320/4885
US-20250051370-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS MAPT 904/4885CA12 3610/4885GMNN 1320/4885
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety SMS, SRM, AAAS MAPT 1100/4885CA12 3801/4885GMNN 601/4885
US-20220064191-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS MAPT 904/4885CA12 3610/4885GMNN 1320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.